Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash Flow for Capital Expenditures
$-765 Mil (TTM As of Jun. 2016)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd's cash flow for capital expenditures for the three months ended in Jun. 2016 was $-175 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2016 was $-765 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Jun. 2016 was -170 (Sep. 2015 ) + -248 (Dec. 2015 ) + -172 (Mar. 2016 ) + -175 (Jun. 2016 ) = $-765 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Cash Flow_CPEX -390-542-681-719-710-1,053-1,104-1,031-929-772

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
Cash Flow_CPEX -225-192-212-300-185-169-170-248-172-175
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK